BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21739307)

  • 1. ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study.
    Li QL; Chen FJ; Lai R; Guo ZM; Luo R; Yang AK
    Med Oncol; 2012 Sep; 29(3):1409-17. PubMed ID: 21739307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZCCHC12, a novel oncogene in papillary thyroid cancer.
    Wang O; Zheng Z; Wang Q; Jin Y; Jin W; Wang Y; Chen E; Zhang X
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1679-1686. PubMed ID: 28424903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
    Zhang H; Teng X; Liu Z; Zhang L; Liu Z
    J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
    Wang N; Jiang R; Yang JY; Tang C; Yang L; Xu M; Jiang QF; Liu ZM
    J Mol Histol; 2014 Aug; 45(4):391-9. PubMed ID: 24276590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma.
    Lan X; Zhang H; Wang Z; Dong W; Sun W; Shao L; Zhang T; Zhang D
    Gene; 2015 Sep; 569(1):109-17. PubMed ID: 26003293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of SERPINA1 as single marker for papillary thyroid carcinoma through microarray meta analysis and quantification of its discriminatory power in independent validation.
    Vierlinger K; Mansfeld MH; Koperek O; Nöhammer C; Kaserer K; Leisch F
    BMC Med Genomics; 2011 Apr; 4():30. PubMed ID: 21470421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?
    Szpak-Ulczok S; Pfeifer A; Rusinek D; Oczko-Wojciechowska M; Kowalska M; Tyszkiewicz T; Cieslicka M; Handkiewicz-Junak D; Fujarewicz K; Lange D; Chmielik E; Zembala-Nozynska E; Student S; Kotecka-Blicharz A; Kluczewska-Galka A; Jarzab B; Czarniecka A; Jarzab M; Krajewska J
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
    Meng XY; Zhang Q; Li Q; Lin S; Li J
    J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.
    Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y
    Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of RASSF1A methylation as a putative molecular marker in papillary thyroid carcinoma.
    Kunstman JW; Korah R; Healy JM; Prasad M; Carling T
    Surgery; 2013 Dec; 154(6):1255-61; discussion 1261-2. PubMed ID: 24383114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
    J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression microarray analysis of papillary thyroid carcinoma and benign thyroid tissue: emphasis on the follicular variant and potential markers of malignancy.
    Finn SP; Smyth P; Cahill S; Streck C; O'Regan EM; Flavin R; Sherlock J; Howells D; Henfrey R; Cullen M; Toner M; Timon C; O'Leary JJ; Sheils OM
    Virchows Arch; 2007 Mar; 450(3):249-60. PubMed ID: 17252232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
    Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene signature of the post-Chernobyl papillary thyroid cancer.
    Handkiewicz-Junak D; Swierniak M; Rusinek D; Oczko-Wojciechowska M; Dom G; Maenhaut C; Unger K; Detours V; Bogdanova T; Thomas G; Likhtarov I; Jaksik R; Kowalska M; Chmielik E; Jarzab M; Swierniak A; Jarzab B
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1267-77. PubMed ID: 26810418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas.
    Bruland O; Fluge Ø; Akslen LA; Eiken HG; Lillehaug JR; Varhaug JE; Knappskog PM
    BMC Cancer; 2009 Dec; 9():425. PubMed ID: 19968886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.
    Barros-Filho MC; Marchi FA; Pinto CA; Rogatto SR; Kowalski LP
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E890-9. PubMed ID: 25867809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
    Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
    BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma.
    Rusinek D; Swierniak M; Chmielik E; Kowal M; Kowalska M; Cyplinska R; Czarniecka A; Piglowski W; Korfanty J; Chekan M; Krajewska J; Szpak-Ulczok S; Jarzab M; Widlak W; Jarzab B
    PLoS One; 2015; 10(12):e0143688. PubMed ID: 26625260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers.
    Ruan DT; Warren RS; Moalem J; Chung KW; Griffin AC; Shen W; Duh QY; Nakakura E; Donner DB; Khanafshar E; Weng J; Clark OH; Kebebew E
    Surgery; 2008 Dec; 144(6):908-13; discussion 913-4. PubMed ID: 19040996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.